Search

Displaying results 6761 - 6770 of 10000 in total
  1. Drug

    Zatebradine

    go.drugbank.com/drugs/DB21228
    Experimental

    The usage of the INN stem '-bradine' in the name indicates that Zatebradine is a bradycardic agent. Zatebradine has a monoisotopic molecular weight of 456.26 Da.

  2. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

  3. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  4. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  5. Drug

    Lonodelestat

    go.drugbank.com/drugs/DB21452
    Experimental

    The usage of the INN stem '-elestat' in the name indicates that Lonodelestat is a elastase inhibitor. Lonodelestat has a monoisotopic molecular weight of 1477.82 Da.

  6. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  7. Drug

    AT9283

    go.drugbank.com/drugs/DB05169
    Investigational

    AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer.

  8. Drug

    Icariin

    go.drugbank.com/drugs/DB12052
    Investigational

    Icariin has been investigated for the basic science of the Pharmacokinetic Profile of Icariin in Humans.

  9. Drug

    NXN-188

    go.drugbank.com/drugs/DB06096
    Investigational

    NXN-188 is a first-in-class, dual-action small molecule incorporating both neuronal nitric oxide synthase (nNOS) inhibition and 5-HT agonism that is being developed for the treatment of acute migraine.

  10. Drug

    D-Glutamic Acid

    go.drugbank.com/drugs/DB02517
    Experimental

    Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.